These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34238324)
1. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. Lu X; Li G; Liu S; Wang H; Chen B J Ovarian Res; 2021 Jul; 14(1):90. PubMed ID: 34238324 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma. Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053 [TBL] [Abstract][Full Text] [Related]
3. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway. Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155 [TBL] [Abstract][Full Text] [Related]
4. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis]. Zhang P; He M; Zeng Y; Cai X Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205 [TBL] [Abstract][Full Text] [Related]
5. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis. Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360 [TBL] [Abstract][Full Text] [Related]
6. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3. Zhang L; Zhang Y; Wang S; Tao L; Pang L; Fu R; Fu Y; Liang W; Li F; Jia W Am J Transl Res; 2020; 12(3):875-888. PubMed ID: 32269720 [TBL] [Abstract][Full Text] [Related]
7. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis. Liu F; Zhang G; Lv S; Wen X; Liu P J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603 [TBL] [Abstract][Full Text] [Related]
8. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Zheng J; Zhou Y; Li XJ; Hu JM Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483 [TBL] [Abstract][Full Text] [Related]
9. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene. Li Y; Zhou J; Wang J; Chen X; Zhu Y; Chen Y Biol Res; 2020 Mar; 53(1):10. PubMed ID: 32156314 [TBL] [Abstract][Full Text] [Related]
10. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399 [TBL] [Abstract][Full Text] [Related]
11. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1. Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736 [TBL] [Abstract][Full Text] [Related]
12. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A. Feng S; Luo S; Ji C; Shi J World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630 [TBL] [Abstract][Full Text] [Related]
13. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner. Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30. Liu Q; Yang H; Hua H Reprod Biol; 2022 Jun; 22(2):100610. PubMed ID: 35313261 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
16. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1. Gong YB; Fan XH Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161 [TBL] [Abstract][Full Text] [Related]
17. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. Zhang C; Li Y; Zhao W; Liu G; Yang Q Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655 [TBL] [Abstract][Full Text] [Related]
18. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. Dong R; Liu X; Zhang Q; Jiang Z; Li Y; Wei Y; Li Y; Yang Q; Liu J; Wei JJ; Shao C; Liu Z; Kong B Oncotarget; 2014 Nov; 5(21):10816-29. PubMed ID: 25333261 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer. Wang JR; Liu B; Zhou L; Huang YX Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803 [TBL] [Abstract][Full Text] [Related]
20. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM. Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]